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ABSTRACT
To utilize effectively the growing number of verified
genes that mediate an organism’s ability to cause
disease and/or to trigger host responses, we have
developed PHI-base. This is a web-accessible data-
base that currently catalogs 405 experimentally
verified pathogenicity, virulence and effector genes
from 54 fungal and Oomycete pathogens, of which
176 are from animal pathogens, 227 from plant
pathogens and 3 from pathogens with a fungal
host. PHI-base is the first on-line resource devoted
to the identification and presentation of information
on fungal and Oomycete pathogenicity genes and
theirhostinteractions.Assuch,PHI-baseisavaluable
resource for the discovery of candidate targets in
medically and agronomically important fungal and
Oomycete pathogens for intervention with synthetic
chemistries and natural products. Each entry in
PHI-baseiscuratedbydomainexpertsandsupported
by strong experimental evidence (gene/transcript
disruption experiments) as well as literature refer-
ences in which the experiments are described. Each
gene in PHI-base is presented with its nucleotide and
deduced amino acid sequence as well as a detailed
description of the predicted protein’s function during
the host infection process. To facilitate data intero-
perability, we have annotated genes using control-
led vocabularies (Gene Ontology terms, Enzyme
Commission Numbers and so on), and provide links
to other external data sources (e.g. NCBI taxonomy
andEMBL).WewelcomenewdataforinclusioninPHI-
base, which is freely accessed at www4.rothamsted.
bbsrc.ac.uk/phibase/.
INTRODUCTION
Pathogenic microbes cause disease in various host organisms
including humans, animals and plants. In agriculture, 10000
fungal species are considered plant pathogenic (1), many caus-
ing severe disease epidemics and lower economic yields.
In human health, there is growing concern over fungal infec-
tions in immuno-compromised patients. The number of genes
conﬁrmed by gene and/or transcript disruption experiments
to be required for the disease causing ability of a microbe
has gradually increased over the past 15 years. These genes
are termed pathogenicity genes if the effect on the phenotype
is qualitative, or virulence/aggressiveness genes if the effect
is quantitative (2). However it is still difﬁcult to access and
compare the resulting data because this is mainly available in
the literature or in the laboratories of individual investigators.
The establishment of a web-accessible database to collate,
cross-link and categorize genotypic and phenotypic informa-
tion of individual pathogens and gene deletion/gene-silenced
mutants will greatly facilitate our understanding of general
pathogenicity mechanisms. For example, the identiﬁcation of
orthologs genes in multiple species could potentially reveal
new generic targets for drug design and may result in the
identiﬁcation of novel strategies for disease control. However,
a reliable source of collated data is an absolute prerequisite to
achieve this objective. In addition, by using an accurate source
of collated data the annotation of newly sequenced genomes
can be achieved by using sequence similarity searches and
homologs of veriﬁed pathogenicity genes detected. Typical
users of this database will be medical and agricultural scient-
ists, bioinformaticians and evolutionary biologists who need
easy access to peer-reviewed data on multiple pathogen spe-
cies from a single internet resource.
PHI-base is designed for hosting any type of pathogen
host interaction and will not be restricted to certain pathogen
species or a range of hosts. Currently several databases are
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doi:10.1093/nar/gkj047available which concentrate only on a speciﬁc host group like
the Fish Pathogen Database (http://dbsdb.nus.edu.sg/fpdb/) or
a sub-set of pathogen taxa such as Fungal Plant Pathogen
Database (3). For instance the Phytopathogenic Fungi and
Oomycete EST Database of COGEME (4) provides sequences
of expressed sequence tags (ESTs) and unisequences (cluster
assembled ESTs) from 15 plant pathogenic species. Gene
sequences can be retrieved through text queries restricted to
certain species based on pre-deﬁned functional classiﬁcation
groups or on sequence similarity. PathoPlant (5) describes
interactions of fungi, bacteria and viruses with plants at the
whole organism level and combines this with information on
the molecular basis of plant defence mechanisms. Links to
external databases and a model signal transduction pathway
are provided, but in contrast to PHI-base PathoPlant covers
only phytopathogens. The fuGIMS database is being
developed to integrate functional and sequence information
from several plant and animal pathogenic fungi with similar
information from Saccharomyces cerevisiae available from
the GIMS database (6). Based on the study of microarray
expression data, DRASTIC Insight (7) collates signal trans-
duction information between plants, pathogens and the envir-
onment, including both biotic and abiotic inﬂuences on plant
disease resistance at the molecular level. Ecological Database
of the World’s Insect Pathogens (EDWIP) (8) and Viral Dis-
eases of Insects in the Literature (VIDIL) (8) offer literature-
based information on fungi, viruses, protozoa, mollicutes,
nematodes and bacteria which are infectious in insects,
mites and related arthropods. Although a wealth of useful
information can be found in EDWIP and VIDIL, these sites
do not contain information on pathogenicity genes. Data man-
agement and analysis for key pathosystems are currently being
developed within the generic framework PathPort (9), which
envisions providing methods to validate candidate target
sequences and predict host response models by exploiting
and integrating data from several pathogen data sources
through GRID technology. What makes PHI-base unique, is
its focus on genes with functions that have been experiment-
ally veriﬁed. These genes are compiled and curated in a way
that can be used to bridge the genotype–phenotype gap under-
lying the interactions between hosts and pathogens.
In the following, we will describe PHI-base and the plans
for future development of this resource.
IDENTIFICATION OF PATHOGENICITY
GENES EXPERIMENTAL EVIDENCE
The only genes included in PHI-base are those which have
been published in peer-reviewed journals as affecting patho-
genicity in one or more gene disruption or gene silencing
experiments. This approach is essential for accurately verify-
ing a role in pathogenicity, and thus determines the design of
the database and the curation process which are described in
the next two sections of this publication. Several approaches
have been taken by the scientiﬁc community to identify patho-
genicity genes in fungal and Oomycete pathogens (Figure 1).
Most of the genes included in PHI-base have arisen through
forward or reverse genetics.
A forward genetics approach is often used to reveal novel
pathogenicity/virulence genes. A library of mutants is created
either by point mutation or insertional mutagenesis. Screening
of large collections of mutants on host organisms can then
reveal mutant strains that possess pathogenicity defects. The
disrupted gene can then be identiﬁed, by complementation in
the case of point mutations or by sequencing the genomic
DNA ﬂanking the mutagenic plasmid in the case of insertional
mutations. This cloned and sequenced gene can only be
classed as a putative pathogenicity gene. If a targeted
deletion experiment in the wild-type strain results in the
same pathogenicity defect, the gene is classiﬁed as a veriﬁed
pathogenicity gene.
A reverse genetics approach has traditionally been used to
identify pathogenicity/virulence gene homologs in multiple
species. Orthologs of the yeast MAP kinases have been iden-
tiﬁed in many different fungal species. Sequence similarity
also showed the yeast FUS3/KSS1 gene to be a pathogenicity
factor in the rice blast fungal pathogen Magnaporthe grisea
(PHI-base accession PHI:56). Since then, orthologs of
this gene have been sequenced, disrupted and shown to affect
pathogenicity in eight other plant and animal fungal
pathogens.
Other approaches for identifying novel pathogenicity/
virulence genes include the use of DNA microarrays, proteo-
mics and metabolomics to identify the genes, proteins and
metabolic pathways that are affected during pathogenicity.
Fungal material can be collected for these studies either dir-
ectly from an infected host, or from in vitro cultures designed
to represent the conditions that exist within an infected host.
Such approaches can reveal changes in gene transcription and
translation and changes in metabolism indicative of a role in
pathogenicity. This information can then be used to identify
candidate genes for silencing, deletion and further character-
ization. The large collections of ESTs and fully sequenced
genomes of many pathogenic fungi are also being used to
identify novel pathogenicity/virulence genes by comparative
genome analysis.
To date, >350 genes have been experimentally veriﬁed as
pathogenicity or virulence genes. In addition, a smaller num-
ber of pathogen effector genes have been demonstrated to be
required to trigger plant defence responses. The rate of gene
discovery has increased from 9 in 1995 to 55 in 2004. This is
Figure 1. Representation of the experiments and criteria needed for a gene to
be entered into PHI-base.
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to increase, through the use of Agrobacterium and improved
protoplast transformation, whilst new techniques such as gene
silencing are employed to identify novel pathogenicity genes.
In addition, the availability of genomic sequence simpliﬁes
the construction of disruption cassettes, and therefore the
rate of gene function discovery can be expected to increase
further.
IMPLEMENTATION AND CURATION
Curation
All data in PHI-base is carefully curated by a domain expert
and supported by strong experimental evidence. PHI-base was
initially populated with data on pathogen host interactions
compiled by researchers of the plant–pathogen interaction
group at Rothamsted Research. The pathway for this manual
data retrieval is shown in Figure 2 (left-hand side). Keyword
searches of the literature databases PubMed/MEDLINE and
Web of Science use the following search string: (fung* or
yeast) and (gene or factor) and (pathogenicity or virulen*
or avirulence gene*).
As only 10% of the returned articles covered patho-
genicity genes, the relevant articles are manually curated by
a domain expert and transferred into a spreadsheet. Further
relevant publications are obtained from recommendations
of internal and external colleagues. To validate and supple-
ment this manual approach, automated text mining methods
are being developed which operate on a local copy of the
MEDLINE database containing more than 15 million refer-
ences to biomedical publications. For this purpose, we have
adapted and extended the ONDEX text mining and database
integration framework (10) to identify and extract relevant
pathogen host interactions from the scientiﬁc literature.
Articles identiﬁed from the novel text mining methods are
carefully curated and checked by a domain expert prior to
inclusion in PHI-base to ensure the same high level of quality
assurance as used in the manual approach.
New releases and updates of PHI-base are created by a
parser which transfers the data from the spreadsheet where
it is currently curated, to the relational database back-end of
PHI-base. This parser also integrates further information from
other external data sources into the spreadsheet. Nucleotide
and protein sequences are extracted from the EMBL sequence
databases and Gene Ontology (GO) annotations. Enzyme
Commission (EC) numbers from the PHI-base curators are
supplemented with GO and EC annotations which also come
from EBI databases. The parser also generates hyperlinks to
external resources such as the NCBI Taxonomy database,
Pubmed links and GO terms. In addition, the parser checks
and enforces syntactic correctness of the data in the spread-
sheet before incorporating information into PHI-base.
Implementation
PHI-base was developed as a relational database using the
database management system PostgreSQL. PHI-base can
be accessed from any web browser through its web interface
which is generated by the server-side scripting language
PHP. Currently, PHI-base is installed on LINUX and uses
the Apache web server, although it can be installed on any
platform that supports PostgreSQL and PHP (i.e. LINUX,
UNIX and Windows). The three-tier architecture of PHI-
base is shown in Figure 2. Users submit database queries
usingthe front-end via HTMLforms. These are then processed
by PHP (middle-tier) against the relational database (back-
end). The result of each query is then presented to the user
in the web browser.
DATABASE DESIGN AND CONTENT
Gene disruption experiments are the experimental basis for
PHI-base and this establishes which genes are essential or
contribute to host infection and disease formation (see
above). The database structure of PHI-base reﬂects this logic
(see Entity Relationship diagram in Figure 3). PHI-base prim-
arily consists of the main tables gene, interaction, species,
disease and paper. Each gene in PHI-base is assigned a stable
unique accession number which will never change between
versions and thus serves as a central reference point in PHI-
base. In addition, each gene is characterized by a number of
attributes such as its name, nucleotide sequence and its func-
tion. Each gene in PHI-base was tested in one or several
interactions with a host. For example, the aspartyl proteinase
genes (SAP1-6) of Candida albicans were all disrupted and
tested for pathogenicity defects in two different animal spe-
cies, i.e. in two pathogen host interactions (PHI:68, PHI:72,
PHI:73, PHI:125–127). Each interaction is supported by at
least one paper. The disease table stores information on the
diseases that are caused by a pathogen. Some pathogens can
cause different diseases, depending on the host they infect.
However, many different fungal pathogens can cause the same
disease across many different hosts. Information on the host
and pathogen species is stored in the species table. A full
Figure 2. Data curation and architecture of PHI-base. Relevant papers are
identifiedbysearchesandby textminingfrom MEDLINE andWebofScience
(WOS). Domain experts curate the data which are then transferred to the
relational back-end of PHI-base. Users can then query PHI-base via its
front-end.
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base table can be found in the online version of PHI-base.
From a technical point of view, we used generalized data
structures for storing the different attributes of each table (11).
This allows the addition of new data ﬁelds according to the
changing requirements of the biological curators without
having to change the database schema. The database schema
is normalized, indexed and wherever it seemed to be sensible,
the data is properly coded.
Arranging the information in such a logical and structured
way facilitates searching the database, which is a prerequisite
for a user-friendly interface. For instance the advanced search
form will aid the user by providing drop-down menus giving
options derived directly from the relational database structure
and contents.
PHI-base contains information about each gene that has
been disrupted and shown to affect pathogenicity in all animal,
fungal and plant attacking fungal and Oomycete pathogens
(Table 1). To date, the genes included in PHI-base are ones
that have been veriﬁed as pathogenicity, virulence or effector
genes. There have been many studies where a gene disruption
has not affected pathogenicity, either owing to functional
redundancy or simply because it is not involved in pathogeni-
city. Currently, very few of these studies have been included
in PHI-base, but their inclusion is envisaged in future updates.
It is important that comparative genomics and gene annota-
tion projects include all the disruption phenotype information
available, including studies which resulted in a wild-type
phenotype (no effect on pathogenicity).
Each gene entry contains several categories of information.
Where the molecular function of a gene product is known, this
is included with the GO term or EC number where applicable
and available. The phenotype of the pathogenicity defect is
summarized in different categories depending on whether the
gene disruption abolishes the ability to cause disease (patho-
genicity gene), reduces the disease causing ability (virulence
gene) or triggers host defence responses (effector). Further
categories summarize where the pathogenicity defect occurs,
i.e. before (pre-), during or after (post-) penetration of the host,
or a combination of these defects (Figure 3).
DATA RETRIEVAL
PHI-base can be searched via its user-friendly interface from
any web browser. Two different search options are provided.
Full text searches can query the complete database or be
restricted to speciﬁc database ﬁelds using the ‘Quick Search’
options. The ‘Advanced Search’ panel allows the user to
Figure 3. Entity relationship diagram of PHI-base. Each gene in PHI-base was tested in one or several interactions with a host. Each interaction is supported by at
leastonepaper.Thediseasetablestoresinformationonthediseaseswhicharecausedbyapathogenhostinteraction.Informationonthehostandpathogenspeciesis
stored in the species table.
Table 1. Summary of the number of pathogen and host species and genes
within Version 2.1 of PHI-base
Host Host
species
Pathogen
species
Pathogenicity
genes
Virulence
genes
Effector
genes
Animal 5* 10* 40 129 0
Plant 32 42 66 110 15
Fungal 3 2 0 3 0
*Five animal species infected by 10 pathogen species.
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genes, diseases, hosts and pathogens can be selected from
(initialized) drop-down menus and then be combined by
AND or OR operators via radio buttons. Each search returns
a result list of distinct pathogen host interactions matching the
search criteria. The listed entries are referenced by a stable
PHI-base identiﬁer and consist of the interactions’ key com-
ponents as retrieved from the underlying publications, parti-
cularly the gene symbol of the experimentally disrupted gene,
a functional annotation of this gene, the pathogen name, the
phenotype that results from disrupting the gene, the disease
that is caused and the host. As far as available, links to external
data sources such as the EMBL Sequence Version Archive
or NCBI Entrez Taxonomy are directly accessible from the
search result list. For any record listed in the result table, the
content of all data ﬁelds are shown in a separate view which
can be accessed via a link in the ﬁrst table column. In addition
to the ﬁelds that further characterize the pathogenicity genes
and their interactions, most notably the gene nucleotide
sequence and the amino acid sequence of the gene product
are given as well as links to the supporting publications in
NCBI PubMed database. In addition, references to papers and
links to supporting publications are included. These may con-
tain information on gene expression, protein expression and
cellular localization or altered interaction phenotypes con-
ferred by variant gene sequences. Users can also download
all PHI-base sequences as a FASTA ﬁle for further computa-
tional analysis and sequence similarity searches.
FUTURE DIRECTIONS
Future versions of PHI-base will also include host mutations
that compromise or enhance host defence responses (12). We
have already compiled from publications >100 Arabidopsis
thaliana mutants and transgenic lines that modify different
types of interactions (13). In addition, for many plant host
species the molecular identity of various classes of disease
resistance (R) genes are now known as well as the function of
speciﬁc gene variants in the activation of plant responses (14).
The combined use of pathogen and host microarray data, as
well as cross-comparisons to viral and bacterial microarray
expression data could lead to the recognition of generic patho-
gen defence pathways and distinguish pathogen-speciﬁc
mechanisms. Genes implicated by weaker types of correlative
evidence stemming from microarray experiments or sequence
similarity searches could be considered for inclusion in
PHI-base in the future. To this end, the type of experimental
evidence will always be annotated, so users can decide for
themselves and specify in the query interface what kind of
evidence they require.
Currently, each entry in PHI-base is annotated with up to
30 different attributes (Figure 3). In future we plan to increase
the number of attributes according to user requests. It is also
planned to improve interoperability with external data sources
by providing linkouts or bidirectional links to related entries.
This will cover the COGEME or fuGIMs databases, as well as
pathway information in KEGG (15).
The main challenge for the future is to keep PHI-base up
to date with the growing number of experimentally veriﬁed
and published pathogenicity genes and to incorporate host
mutants. Towards this goal, we will continue to improve
the text mining support for database curation in terms of ease
of use and precision and recall of the text mining methods.
Development and application of improved methods for iden-
tifying genes in texts such as AbGene (16) or GAPSCORE
(17) are of key importance. However, currently even the most
successful text mining systems extract a certain amount of
incorrect data, which suggests the need for an improved cura-
tion process by involving species speciﬁc domain experts.
Assuring an effective involvement of external experts, we
are currently developing guidelines as well as the computa-
tional infrastructure for external curation support. This will
include advanced web interfaces for data submission and
analysis, as well as methods for keeping track of changes
by external curators.
DATABASE ACCESS
PHI-base can be freely accessed at http://www4.rothamsted.
bbsrc.ac.uk/phibase/. User support can be obtained from this
email phi-base@bbsrc.ac.uk. Please use the same email if you
wish to provide new data for inclusion in PHI-base, are an
interested expert willing to assist with curation or if you have
suggestions for improvements.
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